Literature DB >> 17188100

The open mesh repair of Spigelian hernia.

Angel Celdrán1, José Señaris, José Mañas, Octavio Frieyro.   

Abstract

BACKGROUND: Spigelian hernias are rare defects of the abdominal wall usually appearing between the abdominal muscles, lateral to the rectus abdominis and through a debilitated Spigelian aponeurosis. Recently, mesh repair has been introduced for the treatment of these types of hernias and different approaches have been proposed.
METHODS: Nine patients with Spigelian hernia were prospectively treated by placing a mesh prosthesis between the external oblique and the internal oblique muscles, based on principles of mesh repair established by the Lichtenstein group.
RESULTS: Five women and 4 men, mean age 75.7 years, were operated on. In 1 patient the Spigelian hernia was an incidental finding during an inguinal hernia repair. Two patients were operated on an emergency basis. Elective operations were undertaken in ambulatory facilities in 3. Two patients had postoperative ecchymosis with no associated morbidity. No recurrences have been observed during follow-up.
CONCLUSIONS: Open mesh repair of Spigelian hernias placing the mesh between the external and internal oblique muscles is a simple and safe approach that can prevent morbidity related to other techniques.

Entities:  

Mesh:

Year:  2007        PMID: 17188100     DOI: 10.1016/j.amjsurg.2006.04.016

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Spigelian hernia repair as a day-case procedure.

Authors:  M Zuvela; M Milicevic; D Galun; A Djuric-Stefanovic; P Bulajic; I Palibrk
Journal:  Hernia       Date:  2012-10-18       Impact factor: 4.739

2.  Lateral abdominal wall reconstruction.

Authors:  Donald P Baumann; Charles E Butler
Journal:  Semin Plast Surg       Date:  2012-02       Impact factor: 2.314

3.  Non-traumatic lateral abdominal wall hernia.

Authors:  M Castillo-Sang; B Gociman; B Almaroof; J Fath; F Cason
Journal:  Hernia       Date:  2008-10-24       Impact factor: 4.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.